Cargando…
Transformation of epidermal growth factor receptor T790M mutation‐positive adenosquamous carcinoma of the lung to small cell carcinoma and large‐cell neuroendocrine carcinoma following osimertinib therapy: an autopsy case report
A 59‐year‐old man with relapsed epidermal growth factor receptor (EGFR) exon 19 deletion‐positive stage IA adenosquamous carcinoma after lobectomy was treated with erlotinib and bevacizumab for 1 year followed by erlotinib alone for 1 year. Because of mediastinal and supraclavicular lymphadenopathy...
Autores principales: | Moriguchi, Shuhei, Uruga, Hironori, Fujii, Takeshi, Yasunaga, Yoichi, Takahashi, Yui, Kishi, Kazuma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383305/ https://www.ncbi.nlm.nih.gov/pubmed/30828454 http://dx.doi.org/10.1002/rcr2.402 |
Ejemplares similares
-
Pneumatosis intestinalis induced by osimertinib in a patient with lung adenocarcinoma harbouring epidermal growth factor receptor gene mutation with simultaneously detected exon 19 deletion and T790 M point mutation: a case report
por: Nukii, Yuki, et al.
Publicado: (2019) -
Squamous cell transformation as a mechanism of acquired resistance to tyrosine kinase inhibitor in EGFR‐mutated lung adenocarcinoma: a report of two cases
por: Uruga, Hironori, et al.
Publicado: (2020) -
Combined Adenosquamous and Large Cell Neuroendocrine Carcinoma of the Gallbladder
por: Jung, Jiyoon, et al.
Publicado: (2018) -
An EGFR T790M-mutated lung adenocarcinoma undergoing large-cell neuroendocrine carcinoma transformation after osimertinib therapy: a case report
por: Miyazaki, Shinichi, et al.
Publicado: (2020) -
A patient with a lung adenosquamous carcinoma harboring a de novo T790M mutation and huge nonbacterial vegetative growths successfully treated with osimertinib: A case report
por: Kim, So‐yun, et al.
Publicado: (2023)